TrialScientific reports2021

An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.

Álvaro Réa-Neto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.